Strategic Partners Leverage existing ties with LabCentral and BioLabs from the Cambridge ecosystem to collaborate on field-ready rapid tests, pilot programs, and co-marketing to accelerate validation and deployment of point-of-care diagnostics.

Early Growth Focus Target venture-backed biotech clusters and early-stage hospitals or clinics seeking rapid diagnostics to address fever and infectious disease screening, offering flexible deployment models, training, and data integration.

Public Health Relevance Position solutions around equatorial belt markets and regions with high fever burden, aligning with NIH and Gates Foundation interests to secure non-dilutive or milestone-driven funding plus potential grant-supported pilots.

Technology Enablement Highlight cloud and data capabilities (AWS, RudderStack, PWA) to offer scalable digital health platforms, real-time reporting, and seamless onboarding for clinics lacking centralized lab infrastructure.

Funding & Motive Capitalize on existing seed and Series A momentum and marquee investors (Khosla Ventures, MIT The Engine) to open conversations with potential strategic buyers and implementers seeking innovative diagnostic solutions.